The instrument allows for easy completion of required data bystudy participants

The NuageProduction team includes engineers andmarketing consultants, graphic designers, and project managers. Moreinformation is available at http:// Media Contact: Erin Powers, Powers MediaWorks LLC, for NuageProduction,281.703.6000 or 281.362.1411, RCENuageProductionErin Powers of Powers MediaWorks LLC, 1-281-703-6000, or 1-281-362-1411,, for NuageProduction. Perceptive Informatics Enters License Agreement With EuroQoL Group to ProvideEnhanced Standardization for ePRO SolutionBOSTON, Jan. The license allows Perceptiveto provide EQ-5D, a standardized instrument to measure health-related qualityof life outcomes, through its Electronic Patient Reported Outcomes (ePRO)solution in an Interactive Voice Response (IVR) format. With 83 officiallanguage versions of EQ-5D, the instrument can be used in a wide array ofgeographies for global clinical programs.

EQ-5D is a non-disease specificinstrument, making it applicable to a wide range of health conditions andtreatments. The instrument allows for easy completion of required data bystudy participants. It provides a descriptive profile and a single index valuefor a particular health status."The use of electronic patient reported outcomes in clinical trials hasgrown rapidly, especially as ePRO data, which has been increasingly acceptedby regulators, has expanded beyond efficacy data to include safety,inclusion/exclusion, and medication compliance data. As sponsors are now usingePRO for major therapeutic areas across phases of trials, our goal is to offermore value to clients in this important component of an overall eClinicalplatform," said Steve Kent, President of Perceptive Informatics. As one of themost widely used standardized measures of health status in the world today,there are clear advantages to collecting EQ-5D data electronically.

I expectthat study sponsors, clinical researchers, and patients will be well served bythis agreement between the EuroQoL Group and Perceptive since the IVR formatprovides a highly efficient option for EQ-5D data collection and databasecreation," said Stephen Joel Coons, Ph.D., Member of the EuroQoL Group andProfessor of Pharmacy and Public Health at The University of Arizona.Perceptive's ePRO solution in an IVR format offers an intuitive interfacefor capturing patient reported data, ranging from diaries and validatedinstruments, such as health-related quality of life questionnaires, to complexclinical assessments. Patients can use the Perceptive ePRO system by dialing atoll-free number where they access an application delivered in their ownlanguage. Applications are designed to facilitate rapid progression throughquestions, and responses can be entered easily by using a telephone key pad.Study sponsors and investigator sites can access ePRO data and diarycompliance metrics in real time via an online web reporting capability. TheePRO solution has a rigorous clinical, linguistic, and systems validation inplace.About Perceptive InformaticsPerceptive Informatics, a subsidiary of PAREXEL, is the industry's leadingeClinical solutions provider. Perceptive Informatics offers unprecedentedaccess to innovative eClinical technologies and resources, providing clinicaltrial sponsors, CROs, and other service providers with the benefits of anextensive line of products and services throughout the entire clinicaldevelopment lifecycle. In August, 2008 Perceptive was joined with ClinPhoneplc, and the newly combined organization offers eClinical software andservices that increase the efficiency and productivity of clinical research.Perceptive's expansive product portfolio includes Interactive Voice and WebResponse Systems (IVRS/IWRS,) Medical Imaging, Electronic Data Capture (EDC)systems, Clinical Trial Management Systems (CTMS) and Electronic PatientReported Outcomes (ePRO) solutions, as well as eClinical systems integrationand implementation services. For more information about PerceptiveInformatics, visit http:// PAREXEL InternationalPAREXEL International Corporation is a leading global biopharmaceuticalservices organization, providing a broad range of knowledge-based contractresearch, medical communications and consulting services to the worldwidepharmaceutical, biotechnology and medical device industries.

Committed toproviding solutions that expedite time-to-market and peak-market penetration,PAREXEL has developed significant expertise across the development andcommercialization continuum, from drug development and regulatory consultingto clinical pharmacology, clinical trials management, medical education andreimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, providesadvanced technology solutions, including medical imaging, to facilitate theclinical development process. Headquartered near Boston, Massachusetts,PAREXEL operates in 71 locations throughout 52 countries around the world, andhas over 9,180 employees. For more information about PAREXEL Internationalvisit http:// release contains "forward-looking" statements regarding futureresults and events.